ListarDepartamento de Biología Celular, Fisiología e Inmunología por tema "Neuroendocrine tumors"
Mostrando ítems 1-5 de 5
-
Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
(Nature.com, 2018)Objectives: The association between the presence and alterations of the components of the ghrelin system and the development and progression of neuroendocrine tumors (NETs) is still controversial and remains unclear. Methods: ... -
Identification of novel cellular and/or molecular markers involved in the pharmacological response and contributions of splicing mechanisms in pituitary tumors
(Universidad de Córdoba, UCOPress, 2019) -
Identification of novel molecular markers and contribution of splicing mechanisms in endocrine-related tumoral pathologies
(Universidad de Córdoba, UCOPress, 2020)Cancer represents one of the main challenges for the human being, in that it encompasses some of the most severe and health-threatening pathologies worldwide. Although great efforts are being implemented and significant ... -
Novel diagnostic biomarkers and therapeutic options for neuroendocrine tumors
(Universidad de Córdoba, UCOPress, 2019)Neuroendocriene tumoren (NET) vormen een heterogene groep van zeldzaam voorkomende, langzaam groeiende tumoren. NET ontstaan vanuit enterochromaffine cellen. De jaarlijkse incidentie van NET is progressief toegenomen in ... -
Peptides derived from the extracellular domain of the somatostatin receptor splicing variant 1 SST5TMD4 increase malignancy in multiple cancer cell types
(Elsevier, 2019)Extracellular fragments derived from plasma membrane receptors can play relevant roles in the development/progression of tumor pathologies, thereby offering novel diagnostic or therapeutic opportunities. The truncated ...